Hinge Bio

company

About

Hinge Bio specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$224.45K
Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Hinge Bio is a biotechnology company that specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies. It features chemical ligation process technology that enables the production of therapeutic candidates with orders-of-magnitude improved affinity and specificity.

The company was founded in 2015 and headquartered in Burlingame, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$224.45K
Hinge Bio has raised a total of $224.45K in funding over 2 rounds. Their latest funding was raised on May 22, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 22, 2018 Grant $224.45K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Hinge Bio is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant